Nano-X Imaging Ltd.
ILFinancials
Valuation Metrics
Nano-X Imaging Ltd.'s Market Cap is $21M. At end of 2025 it was $180M. Ranked #3103 of 3,118 in US market (top 100%), #1461 of 1,474 on NASDAQ (top 99%), #201 of 203 in Health Care Equipment & Services (top 99%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $21M | US#3,103/3,118 Sec#201/203 |
| Revenue | $16M | US#2,791/3,118 Sec#198/203 |
| Net Income | $-117M | US—/3,118 Sec—/203 |
| Total Assets | $91M | US#3,056/3,118 Sec#203/203 |
| Net Assets | $72M | US#2,824/3,118 Sec#182/203 |
| Employees | 197 | US#2,482/3,118 Sec#172/203 |
| Value | ||
| P/B | 0.29x | US#42/3,118 Sec#2/203 |
| P/S | 1.35x | US#1,020/3,118 Sec#67/203 |
| FCF Yield | -253.36% | US—/3,118 Sec—/203 |
| Profitability | ||
| ROE | -161.19% | US#2,824/3,118 Sec#187/203 |
| Op. Margin | -654.94% | US#2,788/3,118 Sec#198/203 |
| Revenue Growth | 31.52% | US#394/3,118 Sec#26/203 |
| Financial Health | ||
| Debt Ratio | 25.83% | US#288/3,118 Sec#30/203 |
| Total Debt | $8M | US#2,849/3,118 Sec#190/203 |
| FCF | $-53M | US#2,526/3,118 Sec#178/203 |
| Cash | $31M | US#2,737/3,118 Sec#180/203 |
| Current Ratio | 2.84x | US#832/3,118 Sec#83/203 |
| Performance | ||
| 1Y Return | -91.67% | US#3,120/3,118 Sec#202/203 |
| 1M Return | -52.46% | US#3,102/3,118 Sec#201/203 |
| From 52W High | -93.58% | US#3,118/3,118 Sec#204/203 |
| 1Y MDD | -93.36% | US#3,118/3,118 Sec#204/203 |
| Trading | ||
| Volume | 778,106 shares | US#1,566/3,118 Sec#99/203 |
| Trading Value | $245391.00 | US#3,091/3,118 Sec#201/203 |
| Per Share | ||
| EPS | $-1.68 | US—/3,118 Sec—/203 |
| BPS | $1.04 | US#2,686/3,118 Sec#181/203 |
Company Info
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.